Trial Profile
Adjuvant Treatment by Intra-Arterial Injection of Lipiodol-Labeled Iodine-131 in Preventing Recurrence of Hepatocellular Carcinoma After Curative Treatment.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethiodized oil (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 13 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 13 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2009 New trial record